131 related articles for article (PubMed ID: 4167406)
21. Editorial: hyperthyroidism and Grave's disease.
Br Med J; 1975 May; 2(5969):457-8. PubMed ID: 1173788
[No Abstract] [Full Text] [Related]
22. [TSH and the "long-acting thyroid stimulator" (LATS) in patients with compensated hyperthyroidism].
zur Mühlen A von ; Hesch RD; von Lilienfeld H; Emrich D
Acta Endocrinol Suppl (Copenh); 1971; 152():86. PubMed ID: 5313711
[No Abstract] [Full Text] [Related]
23. Occurrence in thyrotoxicosis of a gamma globulin which protects LATS from neutralization by an extract of thyroid gland.
Adams DD; Kennedy TH
J Clin Endocrinol Metab; 1967 Feb; 27(2):173-7. PubMed ID: 4163610
[No Abstract] [Full Text] [Related]
24. Long acting thyroid stimulator of Graves's disease.
Ochi Y; De Groot LJ
N Engl J Med; 1968 Mar; 278(13):718-21. PubMed ID: 4170527
[No Abstract] [Full Text] [Related]
25. Non-specific responses in the assay of thyrotrophin and long-acting thyroid stimulator.
Adams DD; Kennedy TH; Purves HD
Aust J Exp Biol Med Sci; 1966 Aug; 44(4):355-64. PubMed ID: 5967342
[No Abstract] [Full Text] [Related]
26. Humoral immunity and autoimmune disease.
Roitt IM
Vox Sang; 1969 Apr; 16(4):341-4. PubMed ID: 4184411
[No Abstract] [Full Text] [Related]
27. PRESENCE OF THE LONG-ACTING THYROID STIMULATOR IN SERUM IN MONGOLISM WITHOUT HYPERTHYROIDISM.
MOSIER HD
J Clin Endocrinol Metab; 1965 Aug; 25():1005-8. PubMed ID: 14328369
[No Abstract] [Full Text] [Related]
28. The pathogenesis of thyrotoxicosis the discovery of LATS.
Adams DD
N Z Med J; 1975 Jan; 81(531):15-7. PubMed ID: 1055308
[No Abstract] [Full Text] [Related]
29. [Fluctuations of the long-acting thyroid stimulator (LATS) concentration in the blood and its significance in hyperthyroidism].
Noguchi A; Kurihara H; Ozeki Y; Sato S
Nihon Rinsho; 1967 Oct; 25(8):1723-32. PubMed ID: 5626106
[No Abstract] [Full Text] [Related]
30. Studies on the antigen reacting with the thyroid-stimulating immunoglobulin (LATS) in thyrotoxicosis.
Benhamou-Glynn N; el-Kabir DJ; Roitt IM; Doniach D
Immunology; 1969 Feb; 16(2):187-204. PubMed ID: 4181510
[TBL] [Abstract][Full Text] [Related]
31. [Pitfalls in the biological demonstration of the "long acting thyroid stimulator" (LATS)].
Mertz DP; Stelzer M
Schweiz Med Wochenschr; 1968 Sep; 98(38):1471-5. PubMed ID: 5680881
[No Abstract] [Full Text] [Related]
32. Some observations on a sensitive bioassay for thyrotrophin. Application to normal, hyper- and hypothyroid human serum.
Desbarats-Schönbaum ML; Sellers EA; Belzile A; Schönbaum E
Acta Endocrinol (Copenh); 1967 Feb; 54(2):282-94. PubMed ID: 6071197
[No Abstract] [Full Text] [Related]
33. Inhibition of long-acting thyroid stimulator by thyroid particulate fractions.
Beall GN; Solomon DH
J Clin Invest; 1966 Apr; 45(4):552-61. PubMed ID: 5937026
[No Abstract] [Full Text] [Related]
34. Comparison of the thyroid-stimulating hormone content of serum from thyrotoxic and euthyroid people.
Adams DD; Kennedy TH; Purves HD
J Clin Endocrinol Metab; 1969 Jul; 29(7):900-3. PubMed ID: 5793449
[No Abstract] [Full Text] [Related]
35. An improved bio-assay for the determination of long-acting thyroid stimulator (LATS).
Ason EK; Hetzel BS; Good BF; Stenhouse NS
J Clin Endocrinol Metab; 1967 Nov; 27(11):1529-39. PubMed ID: 6075584
[No Abstract] [Full Text] [Related]
36. Experimental production of a thyroid-stimulating antithyroid antibody.
McKenzie JM
J Clin Endocrinol Metab; 1968 May; 28(5):596-602. PubMed ID: 4172455
[No Abstract] [Full Text] [Related]
37. THE EFFECT OF THYROID HORMONE ON THE LEVELS OF THYROTROPIN (TSH) AND LONG-ACTING THYROID STIMULATOR (L.A.T.S.) IN THYROID DISORDERS.
SAKAGAMI A; FUKUCHI M; MASUI H; MIYAI K; IWATSUBO H; KUMAHARA Y; YOSHIDA T
Med J Osaka Univ; 1964 Mar; 14():235-44. PubMed ID: 14195720
[No Abstract] [Full Text] [Related]
38. CHARACTERIZATION OF THE LONG-ACTING THYROID STIMULATOR OF GRAVES' DISEASE.
MEEK JC; JONES AE; LEWIS UJ; VANDERLAAN WP
Proc Natl Acad Sci U S A; 1964 Aug; 52(2):342-9. PubMed ID: 14206601
[No Abstract] [Full Text] [Related]
39. [Evolution of immunoglobulins IgA, IgM, IgG and LATS during treatment of hyperthyroidism with carmibazole and radioiodine].
Mahaux JE; Delcourt R; Nagel M; Chamla-Soumenkoff J; Levin S
Ann Endocrinol (Paris); 1970; 31(2):314-23. PubMed ID: 4192759
[No Abstract] [Full Text] [Related]
40. Stimulation of the human thyroid by infusions of plasma containing LATS protector.
Adams DD; Fastier FN; Howie JB; Kennedy TH; Kilpatrick JA; Stewart RD
J Clin Endocrinol Metab; 1974 Nov; 39(5):826-32. PubMed ID: 4425101
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
